Philip Halloran, Canada
Defining Relationships Among Tests for Heart Transplant Antibody-Mediated Rejection

Jon Kobashigawa, United States
High Level Donor Derived Cell-Free DNA in Asymptomatic Patients After Heart Transplant - Does It Matter?

Kris Oreschak, United States
Prognostic Value of Donor-Derived Cell-Free DNA in Combination with HLA1 and HLA2 Donor Specific Antibodies After Heart Transplant

Kris Oreschak, United States
Leveraging Longitudinal Donor-Derived Cell-Free DNA and Gene Expression Profiling Data for Acute Cellular Rejection Diagnosis After Heart Transplant

Kris Oreschak, United States
Antibody Mediated Rejection in the Contemporary Donor-Derived Cell-Free DNA Era: An Analysis of the Surveillance HeartCare Outcomes Registry

Kris Oreschak, United States
Impact of Persistently Elevated Simultaneous Gene Expression Profiling and Donor-Derived Cell-Free DNA on Future Clinical Events

Alessia Giarraputo, France
Molecular Classification System for Cardiac Allograft Rejection is Positively Associated with the Pathology Severity of Rejection

Stephanie Golob, United States
Association of ImmuKnow with Post-Transplant Coronary Artery Vasculopathy